enVVeno Medical Corporation

enVVeno Medical Corporation

NVNO
enVVeno Medical CorporationUS flagNASDAQ Capital Market
10.71
USD
-0.04
- -
176,731.00Market Cap

Total Valuation

enVVeno Medical Corporation carries a market capitalization of 176,731.00, placing it among publicly traded companies globally. Its enterprise value stands at -18.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap176,731.00
Enterprise Value-18.21M

Share Statistics

enVVeno Medical Corporation currently has 655,521.00 shares outstanding.

Shares Outstanding655,521.00
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio-0.03
P/TBV Ratio0.26
P/FCF Ratio-0.41
P/OCF Ratio-0.41

Financial Position

enVVeno Medical Corporation maintains a current ratio of 11.89, meaning it holds 11.9x the short-term assets needed to cover near-term liabilities.

Current Ratio11.89
Quick Ratio11.63
Debt / Equity2.54
Debt / EBITDA-0.03
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-56.45
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Stock Price Statistics

enVVeno Medical Corporation's stock has declined approximately -91.80831% over the past 52 weeks. The 50-day moving average sits at 10.86, while the 200-day moving average is 18.87.

Beta (5Y)N/A
52-Week Price Change-91.80831%
50-Day Moving Average10.86
200-Day Moving Average18.87
Average Volume (20 Days)N/A

Income Statement

EBITDA reached -19.52M, while operating income came in at -20.01M.

RevenueN/A
Gross ProfitN/A
Operating Income-20.01M
Pretax Income-18.82M
Net Income-18.82M
EBITDA-19.52M
EBIT-20.01M
Earnings Per Share (EPS)-31.17

Balance Sheet

enVVeno Medical Corporation holds 24.93M in cash and equivalents against 603,000.00 in total debt, resulting in a net debt position of -2.60M. Total book value stands at -175.18M, with working capital of 23.35M providing operational flexibility.

Cash & Cash Equivalents24.93M
Total Debt603,000.00
Net Debt-2.60M
Equity (Book Value)-175.18M
Book Value Per Share-290.13
Working Capital23.35M

Cash Flow

enVVeno Medical Corporation produced -14.79M in operating cash flow over the past twelve months. After subtracting -5,000.00 in capital expenditures, free cash flow totaled -14.79M - equivalent to -24.50 per share.

Operating Cash Flow-14.79M
Capital Expenditures-5,000.00
Free Cash Flow-14.79M
FCF Per Share-24.50

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-16.73
FCF Yield-241.70

Stock Splits

enVVeno Medical Corporation's most recent stock split took place on January 20, 2026 with a 35:1 split ratio.

Last Split Date1/20/2026
Split Ratio35:1

Scores

enVVeno Medical Corporation posts an Altman Z-Score of -9.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-9.29